The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citation
Cited by
Items 501–600 of 634
Trafficking of Osteoclast Precursors
Kikuta, J., Nevius, E., Ishii, M., & Pereira, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00003-7 · Cited by 7
Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists
Horan, J. C., Sanyal, S., Choi, Y., Hill-Drzewi, M., Patnaude, L. A., Anderson, S. M., Fogal, S., Mao, C., Cook, B. N., Gueneva-Boucheva, K., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.003 · Cited by 6
Olesch, C., Brüne, B., & Weigert, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031289 · Cited by 7
Abramczyk, J., Milkiewicz, M., Huła, B., Milkiewicz, P., & Kempińska‐Podhorodecka, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119175 · Cited by 7
“PSC may be an important risk factor for colorectal cancer (CRC) in inflammatory bowel disease (IBD).”
BackgroundInfluentialRole of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury
Sun, G., Wang, B., Zhu, H., Ye, J., & Liu, X. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1265398 · Cited by 11
Cytokines Network and Influenza Virus Infection
Wang, P. Y. X. (2014) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000147 · Cited by 8
One hundred years of (influenza) immunopathology
Boyd, D. F., Wilson, T. L., & Thomas, P. G. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.06.005 · Cited by 6
Song, J., Dagan, A., Yakhtin, Z., Gátt, S., Riley, S., Rosen, H., Or, R., & Almogi‐Hazan, O. (2017) · Oncotarget · doi:10.18632/oncotarget.18626 · Cited by 6
Zhang, F., Hu, W., Qu, L., & Cang, C. (2020) · Channels · doi:10.1080/19336950.2020.1788364 · Cited by 5
“In turn, S1P regulates cell growth, migration, survival, proliferation, and immune responses [1,2].”
BackgroundDash, R. P., Srinivas, N. R., & Rais, R. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4109 · Cited by 6
S1PR3 mediates itch and pain via distinct TRP channel-dependent pathwaysPreprint
Hill, R. Z., Morita, T., Brem, R. B., & Bautista, D. M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235614 · Cited by 6
“Recent studies have linked aberrant S1P signaling to a variety of diseases, including: 466 asthma, multiple sclerosis, cancer, psoriasis, and pain (Brinkmann et al., 2010; Checa et al., 467 2015; Liang et al., 2013; Myśliwiec et al., 2016; Patti et al., 2008; Rivera et al., 2008; F. 468 Roviezzo et al., 2015).”
BackgroundUnpacking the lipid–immune axis in health and disease
Raeisi, M., Yousefi, M., Motavalli, R., Hassanzadeh, A., Seddighi, N., Mehri, M., Ebrahimi, S., Mehdizadeh, A., & Abbasi, K. (2026) · Immunology and Cell Biology · doi:10.1111/imcb.70076 · Cited by 6
“147 S1P polarizes recruited monocytes into either M1 or M2 macrophages.”
Cassarino, M. C., Colado, A., Martínez, V. J. S., Martines, C., Bonato, A., Bertini, M., Pavlovksy, M., Custidiano, R., Bezares, F., Morande, P. E., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91536-5 · Cited by 5
Lysophospholipids: Advances in Synthesis and Biological Significance
Ahmad, M. U., Ali, S. M., Ahmad, A., Sheikh, S., & Ahmad, I. (2015) · Elsevier eBooks · doi:10.1016/b978-1-63067-044-3.50015-7 · Cited by 6
Wang, F., Zhao, S., Gu, Z., Zhao, X., Yang, N., Guan, L., Liu, T., Wang, L., Fang, S., Zhu, C., et al. (2019) · Hematological Oncology · doi:10.1002/hon.2669 · Cited by 7
“S1PR5, which are expressed on the surface of different immune cells.(21) Among them, S1PR5, specifically expressed on the surface of”
BackgroundYang, L., Dong, R., Lu, Y.-W., Wang, H.-M., Kuang, Y.-Q., Wang, R.-R., & Li, Y. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.105985 · Cited by 5
Masuda‐Kuroki, K., Alimohammadi, S., & Nardo, A. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713190 · Cited by 8
“Sphingolipids and their metabolites play crucial roles in cell signaling, cell survival and differentiation, and immune cell trafficking [2,3].”
BackgroundNavigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends
Innani, S., Tomar, Y., Rana, V., & Singhvi, G. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2288273 · Cited by 8
“S1P binds with its five G-protein coupled receptors (S1PR1-S1PR5) present in the immune and endothelial cells to regulate the function of S1P [62].”
BackgroundLuker, A. J., Wukitch, A. M., Kulinski, J. M., Ganesan, S., Kabát, J., Lack, J., Frischmeyer‐Guerrerio, P. A., Metcalfe, D. D., & Olivera, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427509 · Cited by 6
Self-citationThe many facets of biased signaling: Mechanisms and possible therapeutic implications
Solís, K. H., Romero‐Ávila, M. T., Alcántara-Hernández, R., & García-Sáinz, J. A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108877 · Cited by 7
Li, Q., Wang, C., Zhang, Q., Tang, C. X., Li, N., & Li, J. (2012) · Transplantation · doi:10.1097/tp.0b013e31824d709d · Cited by 5
“Maintaining S1P homeostasis is important for appropriate immune responses and vascular barrier integrity (7).”
BackgroundLiu, Y., Yang, K.-L., Wang, L., Yang, J., Wang, Y., Luo, H., Li, P., & Yin, Y. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab150 · Cited by 6
Qiu, L., Jiang, H., Cho, K., Yu, Y., Jones, L. A., Huang, T., Perlmutter, J. S., Gropler, R. J., Brier, M. R., Patti, G. J., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00077 · Cited by 7
Visualizing G Protein-coupled Receptors in Action through Confocal Microscopy Techniques
Castillo‐Badillo, J. A., Cabrera‐Wrooman, A., & García-Sáinz, J. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.03.009 · Cited by 6
Sphingosine-1 Phosphate: A New Player in Osteoimmunology
Boyce, B. F. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.03.002 · Cited by 5
“On the other hand, sphingosine-1 phosphate (S1P) and its receptors control the egress of thymocytes from the thymus, trafficking of lymphocytes in secondary lymphoid organs, and migration of B cells into splenic follicles (reviewed by Rivera et al., 2008).”
BackgroundMulti-Omic Analysis Reveals the Potential Anti-Disease Mechanism of Disease-Resistant Grass Carp
Wang, C., Li, Z., Huang, X., Xu, X., Xu, X., Zhang, K., Zhou, Y., Bai, J., Liu, Z., Jiang, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083619 · Cited by 4
Wang, J., Xu, F., Liu, Y., Zhou, H., Yuan, W., Liu, F., Ye, F., & Liang, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108918 · Cited by 5
Liu, T., Jin, J., Chen, Y., Xi, Q., Hu, J., Jia, W., Chen, X., Li, Y., Wang, X., & Yin, D. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.09.008 · Cited by 5
“In recent studies, S1P1 receptor has become an attractive drug target, involved in occurrence and development of many diseases, especially for immune-mediated diseases [6,7].”
BackgroundPergakis, M. B., Badjatia, N., & Simard, J. M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1876663 · Cited by 4
“The active metabolite of plasma-membrane sphingolipids, sphingosine-1-phosphate (S1P), affects both cell homeostasis and function, acting as a ligand for G-protein-coupled receptors [118].”
BackgroundNardy, A. F. F. R., Santos, L., Freire-de-Lima, C. G., & Morrot, A. (2015) · BioMed Research International · doi:10.1155/2015/709846 · Cited by 4
SEW2871 Alleviates the Severity of Caerulein-Induced Acute Pancreatitis in Mice
Zou, L., Ke, L., Wu, C., Tong, Z., Li, W., Li, N., & Li, J. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00043 · Cited by 6
Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P1 agonists
Tsuji, T., Suzuki, K., Nakamura, T., Goto, T., Sekiguchi, Y., Ikeda, T., Fukuda, T., Takemoto, T., Mizuno, Y., Kimura, T., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.035 · Cited by 4
Haghikia, A., & Gold, R. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.018 · Cited by 4
“…peripheral blood mononuclear cells, the degree and subtype of S1P receptor expression seem to be critical: dendritic cells have been shown to express S1P1–5, T cells only express S1P1 and S1P4 and B cells only S1P1 and S1P3, probably depending on their predominant function (Rivera et al., 2008).”
BackgroundLuo, M., Zhang, W., Yang, J., Du, X., Wang, X., Xu, G., Tang, H., Wang, Z., Zhong, X., Feng, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113526 · Cited by 3
Zhang, M., Rehman, M. U., & Long, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117380 · Cited by 5
Practical synthesis of potent sphingosine-1-phosphate lyase inhibitors THI and LX2931
Zhang, H., Yan, J. R., Bednarz, M. S., Hernández, G., Lu, Y., Courtney, L. F., Chen, J., Hu, W., Liu, R., Yang, X., et al. (2013) · Tetrahedron · doi:10.1016/j.tet.2013.03.071 · Cited by 3
Asano, M., Nakamura, T., Sekiguchi, Y., Mizuno, Y., YAMAGUCHI, T. J., Kuroda, T., Tamaki, K., & Nishi, T. (2013) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2013.02.015 · Cited by 3
Visualizing S1P-directed cellular egress by intravital imaging
Giannouli, C. C., Chandris, P., & Proia, R. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.09.012 · Cited by 3
“Pharmacologic manipulation of S1P1 by FTY720 (and other receptor-active compounds) can block lymphocyte egress, although whether the relevant target is on lymphocytes or the lymphatic endothelium has been a matter of debate [25, 26, 35, 40, 41].”
BackgroundSelf-citationThe Impact of Fingolimod (FTY720) in Neuroimmunologic Diseases
Haghikia, A., & Gold, R. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100200 · Cited by 3
“S1P then exerts its effects via five variably expressed G-protein-coupled receptors, S1P1-5.(5) A variety of immunological properties, among them migration of immune effector cells, cell differentiation, and effector responses assigned to the diversity of S1P receptors, have raised great interest for S1P in the area o…”
BackgroundIshay, Y., Rotnemer-Golinkin, D., & Ilan, Y. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211053274 · Cited by 5
Wu, X., Wabitsch, M., Yang, J. P., & Sakharkar, M. K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286111 · Cited by 3
“The cellular concentration of S1P is in the low nanomolar range, which is much lower than its serum level (~0.5 μ M) [26, 27].”
BackgroundInfluentialLee, S. H., Kim, J. S., & Koh, J. (2023) · Journal of Bone Metabolism · doi:10.11005/jbm.2023.30.4.355 · Cited by 4
“In addition, it has been reported that neither platelets nor mast cells have a role in regulating the homeostatic levels of S1P in blood.”
BackgroundProzorova, Т. М., Kamyshny, A., & Topol, I. A. (2017) · Experimental and Clinical Physiology and Biochemistry · doi:10.25040/ecpb2017.01.023 · Cited by 3
S1P controls endothelial sphingolipid homeostasis via ORMDL
Sasset, L., Chowdhury, K. H., Manzo, O. L., Rubinelli, L., Konràd, C., Maschek, J. A., Manfredi, G., Holland, W. L., & Lorenzo, A. D. (2022) · The FASEB Journal · doi:10.1096/fasebj.2022.36.s1.r5883 · Cited by 3
Ishii, T., Kawamura, S., Nishiyama, I., Kikuta, J., & Ishii, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-800-9_10 · Cited by 3
Hsu, S., Huang, W., Liu, C.-T., Hsu, Y., Chang, J., Huang, S.-K., & Hsu, C.-W. (2019) · Medicine · doi:10.1097/md.0000000000017278 · Cited by 3
Mast Cells: Effector Cells of Anaphylaxis
Tsai, M. M., & Galli, S. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-951-2_4 · Cited by 3
Montrose, D. C., Zhou, X. K., McNally, E. M., Sue, E., Wang, H., Nishiguchi, R., Verma, A., Elemento, O., Simpson, K. W., Yang, P., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.016 · Cited by 4
Protective Role of Sphingosine-1-Phosphate During Radiation-Induced Testicular Injury
Wang, D., Xu, R., & Wang, Z. (2024) · Antioxidants · doi:10.3390/antiox13111322 · Cited by 4
“The interplay of these mechanisms offers multi-level support for the repair of damaged testes [148,149].”
The Dual Faces of S1P: Orchestrating Immune Responses in Health and Disease
Mills, S. A., Barr, D., Mehrotra, S., & Chakraborty, P. (2026) · Cells · doi:10.3390/cells15080663 · Cited by 2
“The function and mechanisms of S1P-S1PR activation in mast cells have been extensively studied using genetic knockout mouse models [34,107–109].”
Sequence analysis of the S1PR1 gene in river buffalo
Stafuzza, N. B., Naressi, B. C. M., Borges, M. M., & Amaral, M. E. J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15016363 · Cited by 2
“The other receptors from this family (S1PR2, S1PR3, S1PR4, and S1PR5) are expressed in only a few cell types of the immune system with an overlapping but distinct pattern of expression according to the tissue (Sanchez and Hla, 2004; Rivera et al., 2008).”
BackgroundGuo, X., Shen, R., Su, Y.-N., & Ma, L. (2023) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0399 · Cited by 2
FTY720 alleviates D-GalN/LPS-induced acute liver failure by regulating the JNK/MAPK pathway
Guan, J., Wu, F., Wu, S., Ren, Y., Wang, J., & Zhu, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114726 · Cited by 3
Ross, F. P. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10018-6 · Cited by 4
Mutabaruka, M.-S., Pata, M., & Vacher, J. (2022) · iScience · doi:10.1016/j.isci.2022.104160 · Cited by 2
“Among the specific signaling effectors regulated by S1P1-Gai interaction is the small G protein Rac1 (Ishii et al., 2010; Sanchez and Hla, 2004; Takuwa, 2002) strongly overexpressed in gl/gl. Activation of Rac1 via S1P1-Gai, likely regulates the rate of gl/glDNdifferentiation kineticandcellmotility.”
BackgroundRole of astrocytes in neuroinflammation (review)
Mordovina, A. I., Rudenko, Е. Е., & Демура, Т. А. (2023) · Saratov Journal of Medical Scientific Research · doi:10.15275/ssmj1901089 · Cited by 2
CD69 regulates the tissue dynamics of epigenetically imprinted memory CD4 + T cells
Hirasawa, R., Iwamura, C., Kiuchi, M., Hishiya, T., Sasaki, A., Kakinuma, K., Ohishi, K., Kurosugi, A., Nemoto, M., Kokubo, K., et al. (2026) · Science Advances · doi:10.1126/sciadv.adw1038 · Cited by 2
“Because lymphatic vessels maintain higher S1P concentrations than the surrounding tissues ( 33 ), iBALT provides an S1P-ennriched microenvironment.”
Gonzales, J. P. M., Tuck, C., Thumu, S. C. R., Munir, S., Harris, J., Tariq, H. (., Marcelli, P., Dominguez, O., Anbazagan, K. S., & Singh, S. K. (2026) · Glia · doi:10.1002/glia.70177 · Cited by 2
“In the immune system, maintenance of an S1P gradient between lymphatic tissue and the blood is important for the extravasation of immune cells in an S1PR1-dependent manner (Rivera et al. 2008).”
Engineering oral commensal nanovaccines to activate mucosal-systemic immune cascades against tumor
Dong, Z., Li, S., Wei, Y., Zhao, J., Kong, W., Liu, W., Chen, J. Y., He, H., Yang, J., & Qi, J. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.06.021 · Cited by 2
New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate
Rapino, C., Standoli, S., Cencetti, F., Bruni, P., Oddi, S., & Maccarrone, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110781 · Cited by 1
“S1P receptors transmit diverse intracellular signals depending on the coupled G α subunits of heterotrimeric G proteins and the expression pattern of each receptor in a given cell (8, 166, 167).”
Ratajczak, M. Z., & Abdelbaset‐Ismail, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802225-2.00002-7 · Cited by 1
Sphingosine Kinases: Biochemistry, Regulation, and Roles
Pitman, M. R., Jarman, K. E., Leclercq, T. M., Pham, D., & Pitson, S. M. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch9 · Cited by 1
Sphingosine 1‐Phosphate (S1P) Receptors
Jung, B., & Hla, T. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch2 · Cited by 2
Xiao, L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.105357 · Cited by 1
Kumar, A., & Saba, J. D. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_452 · Cited by 3
CD34-positive monocytes are highly susceptible to HIV-1Preprint
Takahashi, N., Noyori, O., Komohara, Y., Eltalkhawy, Y. M., Hirayama, M., Yoshida, R., Nakayama, H., Kuroda, M. J., Nomura, T., Ishii, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.26.582226 · Cited by 1
“For instance, S1PR1-acting FTY720 (also known as Fingolimod) which blocks cellular exit from lymph nodes (34), reduced circulating monocytes (29) and the lymph node-to-lymph node trafficking of yersinia pestis -infected monocytes (31).”
BackgroundKing, A. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Huang, J., Wang, X., & Chan, J. (2013) · Wiley eBooks · doi:10.1002/9781118354520.ch12
Imaging vascular development in zebrafish (Danio Rerio)
Nyström, S. (2014) · Figshare
Sphingosine 1‐Phosphate (S1P) Signaling and Lymphocyte Egress
Mendoza, A., Pitt, L. A., & Schwab, S. R. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch22
Tabeling, C. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7458
S1P receptor agonists, a novel generation of immunosuppressants
Almagro, R. L., Tarrasón, G., & Godessart, N. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.018
KLF2's role in T cell trafficking and retention in lymphoid and non-lymphoid tissues
Skon-Hegg, C. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Kikuta, J., Kubo, A., & Ishii, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5366-6_8
Vitamin B9 and ATP in the control and development of intestinal inflammation
Kunisawa, J. (2015) · Inflammation and Regeneration · doi:10.2492/inflammregen.35.014
Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists
Horan, J. C., Kuzmich, D., Liu, P., DiSalvo, D., Lord, J., Mao, C., Hopkins, T. D., Yu, H., Harcken, C., Betageri, R., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.090
PAK1's regulation of eosinophil migration and implications for asthmatic inflammation
Mwanthi, M. (2013) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1720
Choi, K. (2012) · cIRcle (University of British Columbia) · doi:10.14288/1.0073276 · Cited by 1
“When B cells reach the blood, they downregulate the expression of S1P receptors in response to the high levels of S1P, which allows them to follow chemokine gradients to other lymphoid organs (Rivera et al., 2008).”
BackgroundMacrophage Dynamics During Bone Resorption and Chronic Inflammation
Kikuta, J., Nishikawa, K., & Ishii, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_11
Review Article The role of sphingosine 1-phosphate in immunity and sepsis
Gräler, M. H. (2012)
Characterization of the immunoregulatory roles of IFN-β in T cells and dendritic cells
Pennell, L. M. (2017) · TSpace (University of Toronto)
Studies of innate and adaptive lymphocytes in human liver diseases and viral infections
Zimmer, C. L. (2019) · Figshare
Design, Synthesis, and Biological Evaluation of Sphingosine 1-Phosphate Receptor (S1PR) Agonists
Ferracane, M. J. (2014) · doi:10.18130/v3jv8x
“While B cells have increasingly been shown to play a role in RRMS, T cells are the primary drivers of its pathophysiology [47, 59].”
BackgroundDezawa, M. (2020) · Technology & Innovation · doi:10.21300/21.2.2020.143
Prozorova, Т. М., Krupey, K. S., & Kamyshnyi, O. (2020) · Bulletin Of Medical And Biological Research · doi:10.11603/bmbr.2706-6290.2020.1.11118
Tatsumi, N., Codrington, A. L., & Kumamoto, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.276410
“lymphocyte egress from the dLN (Girard et al., 2012; Matloubian et al., 2004; Rivera et al., 2008; Schwab and Cyster, 2007; Shiow et al., 2006), earlier studies demonstrated that the egress shutdown, if any, is transient and is followed by a larger-than-usual efflux from the dLN, making the total flow volume (the numb…”
BackgroundMapping the Molecular Interface of a GPCR Dimer
Li, Z. (2020) · Syracuse University Libraries (Syracuse University)
Mechanisms of Lung Surveillance by Pathogen-Specific Cytotoxic T Lymphocytes
Lee, Y. (2013) · OpenCommons at University of Connecticut (University of Connecticut)
Serum Metabolomic Signatures Associated with Disease Severity in Allergic RhinitisPreprint
Xie, S., Zhang, H., Xie, Z., Liu, Y., Gao, K., Zhang, J., Fan, R., Xie, S., Wang, F., & Jiang, W. (2020) · doi:10.21203/rs.3.rs-40854/v1
“Sphingolipids are ubiquitous components of the cell membrane and play an important role in cell growth, in ammation and tissue remodeling [27-28].”
BackgroundBradley, L. M., & Baaten, B. J. G. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13353033.14724155
McIntyre, T. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.714497863.790052866
(2019) · مجلة دراسات الطفولة · doi:10.21608/jsc.2019.92951
Mapara, M. Y., & Lu, C. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5667958.5640057
Network medicine approaches to diagnostics and therapeutics
Ameli, A. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20383703
Sphingolipidmetabolismus in der akuten Phase der zerebralen Ischämie
Lucaciu, A. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.68193
Efficacy and safety of ozanimod for ulcerative colitis (review)
Шапина, М. В., Полетова, А. В., & Baranova, T. A. (2022) · Koloproktologia · doi:10.33878/2073-7556-2022-21-3-119-129
Graneri, L., Mamo, J. C. L., Takechi, R., & Lam, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00018-0 · Cited by 2
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.